Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK1358820 (Botox) in Strabismus
NCT01584843Phase 3Completed
- Sponsor
- GSK
- Start
- May 2012
- Primary completion
- Jul 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in strabismus, sponsored by GSK. Started May 2012; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
strabismus
Beyond the preview
Go deeper on NCT01584843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01584843.